Publikationen (302) Publikationen, an denen Forscher/innen teilgenommen haben

2020

  1. A more accurate prediction to rule in and rule out pre-eclampsia using the sFlt-1/PlGF ratio and NT-proBNP as biomarkers

    Clinical Chemistry and Laboratory Medicine, Vol. 58, Núm. 3, pp. 399-407

  2. A novel de novo mutation in the PURA gene associated with a new clinical finding: large brainstem

    Journal of Genetics, Vol. 99, Núm. 1

  3. A population-based study of diabetes during pregnancy in Spain (2009–2015): Trends in incidence, obstetric interventions, and pregnancy outcomes

    Journal of Clinical Medicine, Vol. 9, Núm. 2

  4. ADVANCE database characterisation and fit for purpose assessment for multi-country studies on the coverage, benefits and risks of pertussis vaccinations

    Vaccine, Vol. 38, pp. B8-B21

  5. ADVANCE system testing: Benefit-risk analysis of a marketed vaccine using multi-criteria decision analysis and individual-level state transition modelling

    Vaccine, Vol. 38, pp. B65-B75

  6. ADVANCE system testing: Can coverage of pertussis vaccination be estimated in European countries using electronic healthcare databases: An example

    Vaccine, Vol. 38, pp. B22-B30

  7. ADVANCE system testing: Can safety studies be conducted using electronic healthcare data? An example using pertussis vaccination

    Vaccine, Vol. 38, pp. B38-B46

  8. ADVANCE system testing: Estimating the incidence of adverse events following pertussis vaccination in healthcare databases with incomplete exposure data

    Vaccine, Vol. 38, pp. B47-B55

  9. Advance system testing: Vaccine benefit studies using multi-country electronic health data – The example of pertussis vaccination

    Vaccine, Vol. 38, pp. B31-B37

  10. Age-specific vaccination coverage estimates for influenza, human papillomavirus and measles containing vaccines from seven population-based healthcare databases from four EU countries – The ADVANCE project

    Vaccine, Vol. 38, Núm. 16, pp. 3243-3254

  11. An algorithm to identify pregnancies in BIFAP Primary Care database in Spain: Results from a cohort of 155 419 pregnancies

    Pharmacoepidemiology and Drug Safety, Vol. 29, Núm. 1, pp. 57-68

  12. An olaparib window-of-opportunity trial in patients with early-stage endometrial carcinoma: POLEN study

    Gynecologic Oncology, Vol. 159, Núm. 3, pp. 721-731

  13. Analysis of the impact of diagnostic virology tests on the use of antibiotics in paediatric inpatients with community-acquired pneumonia

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 5, pp. 230-233

  14. Angiogenesis biomarkers for the prediction of severe adverse outcomes in late-preterm preeclampsia

    Pregnancy Hypertension, Vol. 19, pp. 74-80

  15. Análisis de casos positivos de cribado neonatal de errores congénitos del metabolismo en la Comunidad de Madrid

    Revista espanola de salud publica, Vol. 94

  16. Análisis del grado de sospecha clínica en pacientes con hiperplasia suprarrenal congénita por déficit de 21 hidroxilasa antes de la obtención del resultado del cribado neonatal en la Comunidad de Madrid

    Revista espanola de salud publica, Vol. 94

  17. Artritis idiopática juvenil y síndrome de Turner

    Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP ), Vol. 93, Núm. 4, pp. 259-261

  18. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

  19. Availability, accessibility and delivery to patients of the 28 orphan medicines approved by the European Medicine Agency for hereditary metabolic diseases in the MetabERN network

    Orphanet Journal of Rare Diseases, Vol. 15, Núm. 1

  20. Base de Datos para la Investigación Farmacoepidemiológica en Atención Primaria (BIFAP): A data resource for pharmacoepidemiology in Spain

    Pharmacoepidemiology and Drug Safety, Vol. 29, Núm. 10, pp. 1236-1245